2.1 Strengths, Doses, and Drug Classes
Key Takeaways
- Strength is the amount of active drug per unit (for example, 10 mg tablet or 5 mg/5 mL); dose is the amount the patient takes at one time or over a day.
- During MTM history and MRP screening, technicians verify that the listed strength, dose, frequency, and drug class match what the patient reports taking.
- Drug class knowledge helps detect therapeutic duplication (two ACE inhibitors) and gaps (no statin when indicated)—always flag clinical judgment items to the pharmacist.
- Common class suffixes and stems (for example, -pril, -olol, -statin, -prazole) speed recognition but do not replace label and profile verification.
- Technicians document discrepancies; pharmacists decide therapy changes, dose adjustments, and clinical interventions.
2.1 Strengths, Doses, and Drug Classes
Quick Answer: In MTM, the technician verifies that each medication’s strength, dose, frequency, and drug class on the profile match what the patient actually takes. Strength is how much drug is in each unit; dose is how much the patient takes. Class knowledge helps spot duplicates and gaps—but clinical substitution and dose changes are pharmacist decisions.
Domain 1 of the PTCB Medication Therapy Management Certificate expects technicians to recognize medication strengths and doses, place drugs into therapeutic classes, and use that product knowledge while building medication histories and screening for medication-related problems (MRPs). This section focuses on verification skills you will use every day in comprehensive medication reviews (CMRs), targeted medication reviews (TMRs), and personal medication record (PMR) updates.
Strength vs. Dose: Precise Definitions
Technicians sometimes use “strength” and “dose” interchangeably. In MTM documentation they are not the same:
| Term | Meaning | Example |
|---|---|---|
| Strength | Amount of active ingredient in one dosage unit or concentration | Lisinopril 10 mg tablets; amoxicillin 400 mg/5 mL suspension |
| Dose | Amount administered at one time (or total daily amount when stated that way) | Take 20 mg (two 10 mg tablets) once daily |
| Frequency / directions | How often and how to take the dose | Once daily in the morning; with food |
| Quantity / days’ supply | How much was dispensed and for how long it should last | 90 tablets; 90-day supply |
A profile that lists “metformin 500 mg” without directions is incomplete for MTM. The technician should clarify whether the patient takes 500 mg once daily, twice daily, or another regimen, then document what the patient reports and flag inconsistencies for the pharmacist.
Unit and concentration traps
- mg vs. mcg: Levothyroxine 75 mcg is not 75 mg. A misplaced unit is a high-priority MRP flag.
- mg vs. mL: Insulin and liquid antibiotics are often ordered in units or volume; confirm whether the patient measures units, mL, or marked syringe lines.
- Combination products: Each component has its own strength (for example, amlodipine/valsartan 5/160 mg). Record both strengths; do not collapse the product into a single number.
- Extended-release vs. immediate-release: Metformin ER 500 mg is not interchangeable with metformin IR 500 mg on a milligram-for-milligram assumption without pharmacist review of dosing and release characteristics.
How Technicians Verify Strength and Dose During MTM History
MTM history collection is more than reading the fill history. Patients may take samples, mail-order fills, medications from another pharmacy, or leftover bottles from old prescriptions. Use a systematic check:
- Ask the patient to show bottles or a current list when possible; compare name, strength, and directions on the label to the claim history.
- Confirm how many units they take (“How many tablets do you take each time?”), not only “Do you take your blood pressure medicine?”
- Reconcile brand and generic names for the same chemical entity so the PMR does not list both as separate therapies.
- Note PRN vs. scheduled use. A patient may have tramadol 50 mg “1–2 tabs every 6 hours PRN” but actually take it three times daily every day—document actual use for the pharmacist.
- Record start date and intended duration when known (for example, antibiotic for 7 days vs. lifelong ACE inhibitor).
MTM technician scenario: strength mismatch
During a CMR, a patient says they take “the little white blood pressure pill, half of it in the morning.” The profile shows carvedilol 25 mg twice daily. The technician asks the patient to describe the tablet and how it is split. The patient produces a bottle labeled carvedilol 3.125 mg. The technician documents the patient-reported strength and regimen, notes the discrepancy with the claim history, and flags the pharmacist before any counseling about heart-failure dosing occurs. The technician does not advise the patient to “just take half of the 25 mg” or change the profile alone.
Drug Classes in MTM Screening
Drug class is the therapeutic category that groups medications with similar mechanisms or indications (for example, ACE inhibitors, SSRIs, HMG-CoA reductase inhibitors). Class fluency supports two core MTM tasks:
- Therapeutic duplication screening: Two drugs from the same class (lisinopril + enalapril) often signal unintended duplication.
- Therapy gap screening: Absence of a usually expected class for a documented condition (no antiplatelet after recent stent) is a potential MRP for pharmacist review—not an automatic order for the technician to create.
High-yield class recognition table for MTM techs
| Class | Common stem / cue | Example agents | MTM screening note |
|---|---|---|---|
| ACE inhibitors | -pril | Lisinopril, enalapril, ramipril | Watch for cough complaints; duplication with another ACEI |
| ARBs | -sartan | Losartan, valsartan | Usually not combined with ACEI without specialist intent |
| Beta blockers | -olol (many) | Metoprolol, carvedilol, atenolol | Confirm IR vs ER and heart-rate goals with pharmacist |
| Calcium channel blockers | -dipine (DHPs) | Amlodipine, nifedipine | Non-DHPs (diltiazem, verapamil) are different subclass |
| Statins | -statin | Atorvastatin, rosuvastatin | Intensity and dose matter for CV risk discussions |
| PPIs | -prazole | Omeprazole, pantoprazole | Long duration without indication is a common TMR flag |
| SSRIs | Variable | Sertraline, fluoxetine, escitalopram | Duplication with another serotonergic agent needs review |
| Biguanides | Metformin family | Metformin IR/ER | Strength + meal timing affect adherence conversations |
| SGLT2 inhibitors | -flozin | Empagliflozin, dapagliflozin | Indication may be diabetes, HF, or CKD—document purpose |
| GLP-1 RAs | Injectables / dual agonists | Semaglutide, dulaglutide | Confirm dose escalation schedule and device strength |
Stems help you recognize a class quickly; they are not a substitute for reading the full drug name, strength, and indication on the label or PMR.
Linking Class Knowledge to MRP Screening
When you screen a medication list, product knowledge turns raw names into actionable flags:
| Observation | Possible MRP category | Technician action |
|---|---|---|
| Lisinopril 40 mg daily + losartan 50 mg daily | Potential duplication / unsafe combo | Flag for pharmacist; do not stop either drug |
| Profile shows warfarin 5 mg; patient reports 7.5 mg Mon/Wed/Fri | Dose discrepancy | Document patient-reported regimen; escalate |
| Two bottles: Synthroid 100 mcg and levothyroxine 100 mcg | Brand/generic duplication risk | Reconcile to one entry after pharmacist confirms |
| Amoxicillin 875 mg BID listed with no stop date, filled 3 months ago | Duration / unnecessary therapy | Ask if course finished; flag stale antibiotic on list |
| Patient with diabetes on no antihyperglycemic, A1C elevated in chart | Possible untreated indication | Flag for pharmacist clinical review |
Technician Support Role Boundaries
Product knowledge empowers technicians to collect, verify, organize, and flag. It does not authorize independent clinical substitution, dose titration, or telling a patient to stop a medicine. In every MTM workflow:
- Technician: Verifies strength/dose/class data; documents patient-reported use; identifies inconsistencies; prepares materials for CMR/TMR.
- Pharmacist: Interprets clinical significance, contacts prescribers, approves therapeutic alternatives, and finalizes the medication action plan (MAP).
Exam items often test whether you escalate the right problem rather than “fixing” therapy yourself. When in doubt, document clearly and involve the pharmacist.
Practical Verification Checklist
Before marking a medication entry complete on a PMR or CMR worksheet, confirm:
- Drug name (generic preferred on PMR, with brand if patient recognizes only the brand).
- Strength and dosage form.
- Dose, route, and frequency as the patient uses them.
- Indication/purpose in patient-friendly terms when known.
- Prescriber and start/stop or ongoing status.
- Any mismatch between claims, bottles, and patient report—flagged.
Mastering strengths, doses, and classes is the foundation for every later Domain 1 skill: terminology, history terms, MRPs, and lab-linked therapy review.
During a CMR, a patient’s profile lists “metformin 500 mg,” and the patient says they take “two pills with breakfast and one with dinner.” What does the technician correctly document as the patient’s dose regimen?
Which finding is the clearest example of potential therapeutic duplication that an MTM technician should flag based on drug class knowledge?
A patient produces bottles labeled Synthroid 75 mcg and levothyroxine 75 mcg from different pharmacies. What is the most appropriate technician action in MTM?
Which statement best describes the MTM technician’s role when verifying strengths and drug classes?